News


September 1, 2016 – NIH awards DxDiscovery a Phase I SBIR for development of a rapid diagnostic for tinea capitis (scalp ringworm)

Tinea capitis (scalp ringworm) is a serious fungal infection that affects 3-8% of children in the United States. Children from disadvantaged socioeconomic backgrounds, sub-Saharan African descent, or other groups that have been traditionally disadvantaged within the health care system are most at risk of infection. Current diagnostics (fungal culture and microscopy) are slow, expensive, (more…)

Read More

June 21, 2016 – NIH awards DxDiscovery a Phase II SBIR for development of a rapid diagnostic for pertussis (whooping cough)

Pertussis (whooping cough) is rapidly re-emerging as a serious public health threat in the United States. Current diagnostics (PCR and culture) are slow, expensive and require a high level of user expertise. The goal of this project is to resolve a critical public health need for improved pertussis diagnostics (more…)

Read More

June 1, 2014 –DxDiscovery begins work on an NIH-funded Phase I SBIR project to develop a rapid diagnostic for pertussis (whooping cough)

Pertussis (whooping cough) is a serious and potentially life-threatening respiratory disease caused by the bacterium Bordetella pertussis. Worldwide, 18.4 million people become ill with pertussis each year, and 254,000 of these patients die. Despite high vaccine coverage in the United States, there were still over 48,000 pertussis cases reported (more…)

Read More

Department of Defense awards DxDiscovery/University of Nevada, Reno $1M Sequential Phase II SBIR

DxDiscovery is continuing efforts to develop medical countermeasures against melioidosis and glanders. These diseases are caused by Burkholderia pseudomallei and Burkholderia mallei, respectively. B. mallei infections are rare, however, B. pseudoamallei infections are a significant cause of morbidity and mortality in southeast Asia.

Read More

Point of Care immunoassay for early diagnosis of pertussis awarded.

National Institutes of Health , National Institute of Allergy and Infectious Disease award number R43AI109891 was awarded to Principal Scientist Amanda Burnham-Marusich and Thomas Kozel for development of a point of care immunoassay for early diagnosis of pertussis on June, 1st 2014.

Read More

Silver and Blue Article

DxDiscovery was featured in the Winter 2014 edition of Silver and Blue Magazine.

Read More

DxD is Sontag Finalist

DxDiscovery announced as one of seven finalists in Sontag competition.

Read More

We Moved

Biotech start-up DxDiscovery moves to Applied Research Facility.

Read More

DxD on MyNews 4

New Nevada biotechnology company DxDiscovery was featured on MyNews 4.

Read More

RGJ Writes About DxD

DxDiscovery was featured in an article by the Reno Gazette Journal.

Read More

New Startup Launches

Biotech start-up launched by School of Medicine researchers.

Read More